Attachments
Key highlights
-
No new cases of cVDPV2 were reported this week. The most recent case (by date of onset) is 21 September 2017 from Boukamal district.
-
The total number of confirmed cVDPV2 cases remains 74.
-
Planning continues for the second phase of the outbreak response. GPEI continues to assist the Syrian Ministry of Health in the planning process.
-
The second phase of the outbreak response will utilize mOPV2 and IPV in two additional immunization rounds through house-to-house and fixed center vaccination.
Immunization response
-
More than 350,000 resident, refugee and internally displaced children have been reached with mOPV2 through two mass vaccination rounds in Deir Ez-Zor and Raqqa governorates since the start of the outbreak.
-
In addition, World Health Organization and UNICEF have coordinated with the Government of Syria and local authorities to reach children aged 2-23 months with IPV in infected and high risk areas of Deir Ez-Zor, Raqqa, Aleppo, Idleb, Hama and Homs governorates and areas of Damascus, Rural Damascus and Hasakah.
-
Senior Expanded Programme on Immunization (EPI) staff are working together with outbreak response teams to prepare for upcoming phase two vaccination activities. Teams are revising and updating microplans to ensure population movements are accounted for and newly accessible areas are included. There has also been mapping of roads for transporting vaccines and centres for vaccine distribution.
-
Communication for Development and Social Mobilization plans for the second phase of outbreak response are being finalized.
-
Processing of the shipment of 815,000 doses of mOPV2 for the second phase of the response is underway.
-
Following the recent training of health staff on mobile data collection, a GAVI-funded field assessment of cold chain capacity is taking place this week in all accessible health facilities.
-
Routine immunization services are being reestablished in Idleb, Aleppo, Hama and Raqqa governorates.